Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M73,083Revenue $M23,113Net Margin (%)16.0Z-Score4.5
Enterprise Value $M73,279EPS $4.3Operating Margin %19.7F-Score5
P/E(ttm))20.7Cash Flow Per Share $5.4Pre-tax Margin (%)20.1Higher ROA y-yN
Price/Book4.110-y EBITDA Growth Rate %12.7Quick Ratio1.3Cash flow > EarningsY
Price/Sales3.35-y EBITDA Growth Rate %0.4Current Ratio1.8Lower Leverage y-yN
Price/Cash Flow9.1y-y EBITDA Growth Rate %-25.8ROA % (ttm)9.9Higher Current Ratio y-yY
Dividend Yield %3.0Insider Buy (3m)1ROE % (ttm)19.7Less Shares Outstanding y-yY
Payout Ratio %62.0Shares Outstanding M1,119ROI % (ttm)23.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYGeorge Soros 2014-06-30 Buy 0.02%$58.21 - $63.1
($59.62)
$ 65.239%New holding, 50441 sh.50,441
LLYVanguard Health Care Fund 2014-06-30 Reduce-0.15%$58.21 - $63.1
($59.62)
$ 65.239%Reduce -3.98%21,982,700
LLYJohn Hussman 2014-06-30 Reduce-0.02%$58.21 - $63.1
($59.62)
$ 65.239%Reduce -50%5,000
LLYRay Dalio 2014-06-30 Sold Out -0.02%$58.21 - $63.1
($59.62)
$ 65.239%Sold Out0
LLYPRIMECAP Management 2014-03-31 Add0.37%$50.73 - $59.85
($55.61)
$ 65.2317%Add 10.83%57,129,708
LLYJoel Greenblatt 2014-03-31 Reduce-0.16%$50.73 - $59.85
($55.61)
$ 65.2317%Reduce -93.61%9,016
LLYRay Dalio 2014-03-31 Reduce-0.01%$50.73 - $59.85
($55.61)
$ 65.2317%Reduce -34.83%31,439
LLYVanguard Health Care Fund 2013-12-31 Add0.67%$47.65 - $51.34
($50.05)
$ 65.2330%Add 22.98%22,895,000
LLYCharles Brandes 2013-12-31 Add0.19%$47.65 - $51.34
($50.05)
$ 65.2330%Add 12.57%2,711,949
LLYJoel Greenblatt 2013-12-31 Add0.11%$47.65 - $51.34
($50.05)
$ 65.2330%Add 201.79%141,121
LLYRay Dalio 2013-12-31 Add0.01%$47.65 - $51.34
($50.05)
$ 65.2330%Add 153.37%48,239
LLYVanguard Health Care Fund 2013-09-30 Add0.46%$49.92 - $54.96
($52.42)
$ 65.2324%Add 16.91%18,617,000
LLYCharles Brandes 2013-09-30 Add0.23%$49.92 - $54.96
($52.42)
$ 65.2324%Add 16.93%2,409,134
LLYPRIMECAP Management 2013-09-30 Add0.13%$49.92 - $54.96
($52.42)
$ 65.2324%Add 3.98%50,846,997
LLYDavid Dreman 2013-09-30 Buy 0.02%$49.92 - $54.96
($52.42)
$ 65.2324%New holding, 4290 sh.4,290
LLYRay Dalio 2013-09-30 Buy 0.01%$49.92 - $54.96
($52.42)
$ 65.2324%New holding, 19039 sh.19,039
LLYJohn Hussman 2013-09-30 Reduce-1.58%$49.92 - $54.96
($52.42)
$ 65.2324%Reduce -98.57%10,000
LLYJohn Hussman 2013-06-30 Add0.23%$49.06 - $58.33
($54.41)
$ 65.2320%Add 16.64%701,000
LLYPRIMECAP Management 2013-06-30 Add0.14%$49.06 - $58.33
($54.41)
$ 65.2320%Add 4.39%48,900,865
LLYJoel Greenblatt 2013-06-30 Add0.07%$49.06 - $58.33
($54.41)
$ 65.2320%Add 894.98%39,411
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
LLY George Soros 2014-06-3050,44100.02New Buy
LLY David Dreman 2014-06-305,76900.03+11.33%
LLY PRIMECAP Management 2014-06-3057,102,8405.13.9-0.05%
LLY Charles Brandes 2014-06-302,686,2580.242-0.62%
LLY Mario Gabelli 2014-06-30120,0000.010.04-0.74%
LLY Dodge & Cox 2014-06-3035,27400-1.36%
LLY Vanguard Health Care Fund 2014-06-3021,982,7001.963.6-3.98%
LLY Joel Greenblatt 2014-06-307,74900.01-14.05%
LLY John Hussman 2014-06-305,00000.02-50%
LLY Ray Dalio 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2014-09-10Sell210,000$64.770.88view
LILLY ENDOWMENT INC10% Owner 2014-09-03Sell200,000$63.992.11view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2014-09-02Sell5,000$63.62.74view
LILLY ENDOWMENT INC10% Owner 2014-07-29Sell250,000$63.033.66view
Mahony SusanSVP & Pres., Lilly Oncology 2014-07-28Sell2,065$63.33.22view
Mahony SusanSVP & Pres., Lilly Oncology 2014-07-25Sell30,000$63.92.25view
Conterno Enrique ASr. VP & Pres., Lilly Diabetes 2014-07-25Sell10,000$63.792.43view
LILLY ENDOWMENT INC10% Owner 2014-07-01Sell235,000$62.34.88view
LILLY ENDOWMENT INC10% Owner 2014-06-25Sell245,000$62.684.24view
LILLY ENDOWMENT INC10% Owner 2014-06-20Sell230,000$61.626.04view

Press Releases about LLY :

    Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    Weekly 52-Week Highs Highlight: LLY, BG, NVS, HRL Sep 07 2014 
    Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures Aug 28 2014 
    Eli Lilly is on the Right Track Jun 25 2014 
    John Paulson's Stocks Trading for Less Than He Paid for Them Jun 02 2014 
    Johnson & Johnson (JNJ) Dividend Stock Analysis May 29 2014 
    Can Pfizer Make Up Its Loss? May 09 2014 
    Will Pfizer’s Q1 2014 Earnings Beat the Street on May 5, 2014? May 05 2014 
    Vanguard Health Care Fund's Top Quarterly Holdings Apr 30 2014 
    These Three Pharmaceutical Companies Shake The Market With Their Deal Apr 27 2014 
    Forest Laboratories' Recovery Mar 18 2014 


    More From Other Websites
    Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries Sep 29 2014
    [video] Shah Favors Big Pharmaceuticals Focused on Obesity Sep 26 2014
    Must-know: Highfields Capital starts a new position in Eli Lilly Sep 25 2014
    Must-know: Highfields Capital adds a new position in Hertz Global Sep 25 2014
    When It Comes To Its Reputation, The Pharmaceutical Industry Continues To Mess Up Sep 24 2014
    A blast from Martha's past: Waksal plans new IPO Sep 24 2014
    ImClone's Waksal plans IPO Sep 24 2014
    Eli Lilly's Trulicity Approved by FDA for Type II Diabetes Sep 19 2014
    F.D.A. Approves Trulicity, a Drug for Type 2 Diabetes Sep 18 2014
    FDA Approves Trulicity™ (dulaglutide), Lilly's Once-Weekly Therapy for Adults with Type 2 Diabetes Sep 18 2014
    FDA approves Eli Lilly's injectable diabetes drug Sep 18 2014
    FDA approves Eli Lilly's injectable diabetes drug Sep 18 2014
    Bayer Deal for Zoetis in Sight After Unit Sale: Real M&A Sep 18 2014
    FDA Approves Lilly's Once-Weekly Shot For Diabetes Sep 18 2014
    Elanco Animal Health, Dow AgroSciences Announce Strategic R&D Agreement Sep 18 2014
    CYRAMZA™ In Combination With Paclitaxel Significantly Improves Overall Survival In Second-Line... Sep 18 2014
    FDA panel backs limiting use of testosterone replacement drugs Sep 17 2014
    Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone Sep 17 2014
    AstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug Sep 16 2014
    Pharma in focus: Ebola & Enterovirus D68 Sep 16 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK